Gold Standard:Pathologic diagnosis.
Sponsors
Peking University Shenzhen Hospital, Shanghai Pulmonary Hospital affiliated to Tongji University, Shanghai Sixth People's Hospital, The University of Hong Kong-Shenzhen Hospital, Renji Hospital Affiliated to Medical School of Shanghai Jiaotong University
Conditions
Breast diseaseCancerEsophageal cancerProstate cancerSoft tissue massSubpleural pulmonary lesionsThyroid cancernasopharyngeal carcinoma
Early Phase 1
Researc for the biomarkers of invasion and recurrence in nasopharyngeal carcinoma and the functional validation
RecruitingChiCTR1900024704
Start: 2019-07-25Updated: 2019-07-29
Technical standard and application of intelligence assisted ultrasound indiagnosis of subpleural lung lesions
Active, not recruitingChiCTR2000029823
Start: 2020-04-01Updated: 2020-02-17
Construction of artificial intelligence-assisted prostate tumor early diagnosis system based on surface enhanced Raman spectroscopy
RecruitingChiCTR2000037082
Start: 2020-10-01Updated: 2020-10-05
Establishment and validation of multi-dimensional risk model for early esophageal cancer and precancerous lesions
Active, not recruitingChiCTR2000037124
Start: 2021-01-01Updated: 2020-10-05
Study on accurate diagnosis and treatment of differentiated thyroid carcinoma with pulmonary metastasis based on artificial intelligence and multiomics analysis
RecruitingChiCTR2000037168
Start: 2020-10-01Updated: 2020-10-05
Cohort study of novel prostate biomarkers for the early diagnosis of prostate cancer
RecruitingChiCTR2000041553
Start: 2020-12-29Updated: 2021-04-12
A prospective, multicenter cohort study of pan-cancer screening in Chinese population
RecruitingChiCTR2100053705
Start: 2021-12-01Updated: 2022-10-17
The study of novel microbial markers for prostate cancer diagnosis
RecruitingChiCTR2400084633
Start: 2024-05-21Updated: 2024-05-27
Unknown Phase
Application of Automated Breast Volume Imaging System in Breast Cancer Diagnosis
Active, not recruitingChiCTR2000030124
Start: 2020-03-01Updated: 2020-02-25
Reliminary study for benign and malignant soft tissue mass prediction based on MRI features of radiomics
Active, not recruitingChiCTR2000032572
Start: 2020-07-01Updated: 2020-05-04